A detailed history of Advisors Asset Management, Inc. transactions in Argenx Se stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 927 shares of ARGX stock, worth $582,452. This represents 0.01% of its overall portfolio holdings.

Number of Shares
927
Previous 804 15.3%
Holding current value
$582,452
Previous $345,000 45.51%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$434.22 - $551.9 $53,409 - $67,883
123 Added 15.3%
927 $502,000
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $76,898 - $97,534
216 Added 36.73%
804 $345,000
Q1 2024

May 14, 2024

BUY
$356.95 - $413.29 $92,807 - $107,455
260 Added 79.27%
588 $231,000
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $77,271 - $115,370
228 Added 228.0%
328 $124,000
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $36,014 - $42,258
100 New
100 $38,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.